Skip to content

Author

G. Gaidano

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Progression-free survival prediction in diffuse large B-cell lymphoma: where can we further improve?

INTRODUCTION Diffuse large B-cell lymphoma (DLBCL) is a biologically heterogeneous disease in which approximately one-third of patients experience primary refractoriness or relapse despite modern chemoimmunotherapy. Although clinical prognostic indices remain the cornerstone of risk stratification, they incompletely ca...

N. Maher, R. Moia, G. Gaidano · 0 citations
#protein folding Open access Oct 2026

BTK/BCL2 dual targeting enhances apoptosis in marginal zone lymphoma: preclinical activity of tacabrutideg (BGB-16673) and sonrotoclax.

Tacabrutideg demonstrates potent preclinical activity in MZL as a single agent and in combination regimens, and together with the superior activity of sonrotoclax, these findings provide a strong rationale for the clinical evaluation of dual BTK degradation and BCL2 inhibition in patients with MZL.

A. Arribas, Alex Zadro, E. Civanelli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.